Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiyong Han

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
World Journal of Gastroenterology|December 21, 2017
Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumorsAhmad Al-Hader, Rami N Al-Rohil, Haiyong Han, et al.
Cancer Treatment and Research|June 19, 2019
Single-Cell Sequencing in Precision MedicineJulia E Wiedmeier, Pawan Noel, Wei Lin, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic CancerYuan Li, Caiming Xu, Haiyong Han, et al.
Molecular Cancer Therapeutics|January 12, 2008
Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cellsBret Stephens, Haiyong Han, Galen Hostetter, et al.
Frontiers in Genetics|January 11, 2020
Ultra-Sensitive Automated Profiling of EpCAM Expression on Tumor-Derived Extracellular VesiclesPouya Amrollahi, Meryl Rodrigues, Christopher J Lyon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cellsCaroline H Diep, Ruben M Munoz, Ashish Choudhary, et al.
Cancer Discovery|November 5, 2011
Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second lookClifford J Whatcott, Haiyong Han, Richard G Posner, et al.
Journal of Medicinal Chemistry|February 13, 2014
Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibitionBrendan Frett, Robert V Brown, Mingliang Ma, et al.
Expert Opinion on Therapeutic Targets|December 9, 2004
Hitting multiple targets with multimeric ligandsHeather L Handl, Josef Vagner, Haiyong Han, et al.
Trends in Pharmacological Sciences|April 13, 2019
Triptolide and Its Derivatives as Cancer TherapiesPawan Noel, Daniel D Von Hoff, Ashok K Saluja, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
World Journal of Gastroenterology|December 21, 2017
Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumorsAhmad Al-Hader, Rami N Al-Rohil, Haiyong Han, et al.
Cancer Treatment and Research|June 19, 2019
Single-Cell Sequencing in Precision MedicineJulia E Wiedmeier, Pawan Noel, Wei Lin, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic CancerYuan Li, Caiming Xu, Haiyong Han, et al.
Molecular Cancer Therapeutics|January 12, 2008
Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cellsBret Stephens, Haiyong Han, Galen Hostetter, et al.
Frontiers in Genetics|January 11, 2020
Ultra-Sensitive Automated Profiling of EpCAM Expression on Tumor-Derived Extracellular VesiclesPouya Amrollahi, Meryl Rodrigues, Christopher J Lyon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cellsCaroline H Diep, Ruben M Munoz, Ashish Choudhary, et al.
Cancer Discovery|November 5, 2011
Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second lookClifford J Whatcott, Haiyong Han, Richard G Posner, et al.
Journal of Medicinal Chemistry|February 13, 2014
Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibitionBrendan Frett, Robert V Brown, Mingliang Ma, et al.
Expert Opinion on Therapeutic Targets|December 9, 2004
Hitting multiple targets with multimeric ligandsHeather L Handl, Josef Vagner, Haiyong Han, et al.
Trends in Pharmacological Sciences|April 13, 2019
Triptolide and Its Derivatives as Cancer TherapiesPawan Noel, Daniel D Von Hoff, Ashok K Saluja, et al.
Pageof 10